Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-31 @ 3:43 PM
Study NCT ID:
NCT03290794
Status:
COMPLETED
Last Update Posted:
2023-06-09
First Post:
2017-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-26
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-20
First Submit QC Date:
None
Study First Post Date:
2017-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-08
Last Update Post Date:
2023-06-09
Last Update Post Date Type:
ACTUAL